Cytokinetics
CYTK
#2280
Rank
A$12.08 B
Marketcap
A$98.87
Share price
-1.31%
Change (1 day)
26.52%
Change (1 year)

Cytokinetics (CYTK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$2.94 Billion

According to Cytokinetics 's latest financial reports the company's total liabilities are A$2.94 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cytokinetics - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$2.47 B39.07%
2023-12-31A$1.77 B7.71%
2022-12-31A$1.64 B100.19%
2021-12-31A$0.82 B50.72%
2020-12-31A$0.54 B27.28%
2019-12-31A$0.42 B63.36%
2018-12-31A$0.26 B10.99%
2017-12-31A$0.23 B125.36%
2016-12-31A$0.10 B64.18%
2015-12-31A$64.03 M28.11%
2014-12-31A$49.98 M55.09%
2013-12-31A$32.22 M348.57%
2012-12-31A$7.18 M60.32%
2011-12-31A$4.48 M-39.11%
2010-12-31A$7.35 M-68.77%
2009-12-31A$23.56 M-55.88%
2008-12-31A$53.41 M-15.78%
2007-12-31A$63.42 M-20.89%
2006-12-31A$80.17 M227.74%
2005-12-31A$24.46 M-7.86%
2004-12-31A$26.54 M-87.26%
2003-12-31A$0.20 B0.56%
2002-12-31A$0.20 B-9.12%
2001-12-31A$0.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.79 B-73.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A$63.97 M-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.40 B-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$121.22 B 4,013.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$1.81 B-38.37%๐Ÿ‡บ๐Ÿ‡ธ USA